A post hoc analysis of the effect of viloxazine extended-release capsules on learning and school problems in children and adolescents with attention-deficit/hyperactivity disorder.

Improvement in attention-deficit/hyperactivity disorder (ADHD) symptoms vs. placebo was reported in a series of pediatric clinical trials of viloxazine extended-release capsules (viloxazine ER; Qelbree™). This post hoc analysis of those studies evaluated the effect of viloxazine ER on learning and s...

Full description

Bibliographic Details

Published in:	European Child & Adolescent Psychiatry Vol. 32; no. 3; pp. 491 - 500
Main Authors:	Faraone, Stephen V., Gomeni, Roberto, Hull, Joseph T., Busse, Gregory D., Melyan, Zare, Rubin, Jonathan, Nasser, Azmi
Format:	clinical trial research tables/charts Journal Article
Published:	Springer Nature Mar2023
Online Access:	View this record in EBSCOhost